Gilead’s remdesivir slows progression of Covid-19 in monkeys: Study
Reuters |
Reuters| Posted by Susmita Pakrasi In the study, macaques that received remdesivir did not show signs of respiratory disease and had reduced damage to the lungs, according to the study authors.
Gilead Sciences Inc’s antiviral drug, remdesivir, prevented lung disease in macaques infected with the new coronavirus, a study published in medical journal Nature said on Tuesday.
In the study, macaques that received remdesivir did not show signs of respiratory disease and had reduced damage to the lungs, according to the study authors.
Unlock a world of Benefits with HT! From insightful newsletters to real-time news alerts and a personalized news feed – it's all here, just a click away! - Login Now! Get Latest World News along with Latest News from India at Hindustan Times.